Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Proteome Res ; 13(7): 3444-54, 2014 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-24922590

RESUMO

Prostate cancer (PCa) is the second leading cause of cancer-related mortality in men. The prevalent diagnosis method is based on the serum prostate-specific antigen (PSA) screening test, which suffers from low specificity, overdiagnosis, and overtreatment. In this work, untargeted metabolomic profiling of age-matched serum samples from prostate cancer patients and healthy individuals was performed using ultraperformance liquid chromatography coupled to high-resolution tandem mass spectrometry (UPLC-MS/MS) and machine learning methods. A metabolite-based in vitro diagnostic multivariate index assay (IVDMIA) was developed to predict the presence of PCa in serum samples with high classification sensitivity, specificity, and accuracy. A panel of 40 metabolic spectral features was found to be differential with 92.1% sensitivity, 94.3% specificity, and 93.0% accuracy. The performance of the IVDMIA was higher than the prevalent PSA test. Within the discriminant panel, 31 metabolites were identified by MS and MS/MS, with 10 further confirmed chromatographically by standards. Numerous discriminant metabolites were mapped in the steroid hormone biosynthesis pathway. The identification of fatty acids, amino acids, lysophospholipids, and bile acids provided further insights into the metabolic alterations associated with the disease. With additional work, the results presented here show great potential toward implementation in clinical settings.


Assuntos
Biomarcadores Tumorais/sangue , Neoplasias da Próstata/diagnóstico , Idoso , Biomarcadores Tumorais/isolamento & purificação , Estudos de Casos e Controles , Cromatografia Líquida de Alta Pressão , Estudos de Viabilidade , Humanos , Masculino , Metabolômica , Pessoa de Meia-Idade , Neoplasias da Próstata/sangue , Espectrometria de Massas em Tandem
2.
Sci Rep ; 5: 16351, 2015 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-26573008

RESUMO

High performance mass spectrometry was employed to interrogate the serum metabolome of early-stage ovarian cancer (OC) patients and age-matched control women. The resulting spectral features were used to establish a linear support vector machine (SVM) model of sixteen diagnostic metabolites that are able to identify early-stage OC with 100% accuracy in our patient cohort. The results provide evidence for the importance of lipid and fatty acid metabolism in OC and serve as the foundation of a clinically significant diagnostic test.


Assuntos
Biomarcadores Tumorais/sangue , Detecção Precoce de Câncer/normas , Metabolômica , Neoplasias Ovarianas/sangue , Neoplasias Ovarianas/patologia , Adulto , Idoso , Antígeno Ca-125/sangue , Estudos de Casos e Controles , Cromatografia Líquida de Alta Pressão , Feminino , Humanos , Lisofosfolipídeos/sangue , Metaboloma , Pessoa de Meia-Idade , Neoplasias Ovarianas/metabolismo , Análise de Componente Principal , Sensibilidade e Especificidade , Máquina de Vetores de Suporte , Espectrometria de Massas em Tandem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa